High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitis.

J Pediatr Gastroenterol Nutr · 2014 · PMC4255757 · PMID 25419597

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

The biomarker data suggest a numerical trend toward higher efficacy at the high dose versus the low dose.

also in 723 other papers

did not reach statistical significanceno p-value reported

The reduction in fecal biomarkers, especially lactoferrin, tended to be greater and occurred in a higher proportion of patients in the high-dose group, but this did not reach statistical significance (Table 5 ).

also in 75,278 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.